Pfizer, Novartis, Lilly drugs in latest round of Medicare drug price negotiations
Source: SeekingAlpha
2026-01-27 18:20:47 ET
More on Pfizer, Eli Lilly
- Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance
- Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)
- Eli Lilly: Breakout To New Highs Sends A Clear Warning Shot
- Healthcare lobbying efforts reach record high in Washington: report
- Pediatrics group defies CDC, endorses COVID, flu shots for children
Read the full article on Seeking Alpha
For further details see:
Pfizer, Novartis, Lilly drugs in latest round of Medicare drug price negotiations
Novartis AG
NASDAQ: NVS
NVS Trading
-3.58% G/L:
$145.09 Last:
659,217 Volume:
$146.92 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
